These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20510231)

  • 41. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.
    van Gaalen FA; Linn-Rasker SP; van Venrooij WJ; de Jong BA; Breedveld FC; Verweij CL; Toes RE; Huizinga TW
    Arthritis Rheum; 2004 Mar; 50(3):709-15. PubMed ID: 15022309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis.
    Falkenburg WJJ; van Schaardenburg D
    Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):42-52. PubMed ID: 29221597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
    Yamada R; Suzuki A; Chang X; Yamamoto K
    Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
    Verpoort KN; van Gaalen FA; van der Helm-van Mil AH; Schreuder GM; Breedveld FC; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis.
    Kokkonen H; Brink M; Hansson M; Lassen E; Mathsson-Alm L; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2015 May; 17(1):125. PubMed ID: 25990747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of Anti-Citrullinated Protein Antibodies and IgM Rheumatoid Factor in First-Degree Relatives of Dutch Rheumatoid Arthritis Patients.
    Maijer KI; Gerlag DM; Tak PP
    Arthritis Rheumatol; 2015 Dec; 67(12):3324-6. PubMed ID: 26315149
    [No Abstract]   [Full Text] [Related]  

  • 47. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.
    Mahdi H; Fisher BA; Källberg H; Plant D; Malmström V; Rönnelid J; Charles P; Ding B; Alfredsson L; Padyukov L; Symmons DP; Venables PJ; Klareskog L; Lundberg K
    Nat Genet; 2009 Dec; 41(12):1319-24. PubMed ID: 19898480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies to citrullinated proteins: pathogenic and diagnostic significance.
    Holers VM
    Curr Rheumatol Rep; 2007 Oct; 9(5):396-400. PubMed ID: 17915095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of autoantibodies in the pathophysiology of rheumatoid arthritis.
    Derksen VFAM; Huizinga TWJ; van der Woude D
    Semin Immunopathol; 2017 Jun; 39(4):437-446. PubMed ID: 28451788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
    van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
    Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
    Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
    de Brito Rocha S; Baldo DC; Andrade LEC
    Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients.
    Demoruelle MK; Harrall KK; Ho L; Purmalek MM; Seto NL; Rothfuss HM; Weisman MH; Solomon JJ; Fischer A; Okamoto Y; Kelmenson LB; Parish MC; Feser M; Fleischer C; Anderson C; Mahler M; Norris JM; Kaplan MJ; Cherrington BD; Holers VM; Deane KD
    Arthritis Rheumatol; 2017 Jun; 69(6):1165-1175. PubMed ID: 28182854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B cell autoimmunity and bone damage in rheumatoid arthritis.
    Bugatti S; Bogliolo L; Montecucco C; Manzo A
    Reumatismo; 2016 Dec; 68(3):117-125. PubMed ID: 27981813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study.
    Gan RW; Young KA; Zerbe GO; Demoruelle MK; Weisman MH; Buckner JH; Gregersen PK; Mikuls TR; O'Dell JR; Keating RM; Clare-Salzler MJ; Deane KD; Holers VM; Norris JM
    Rheumatology (Oxford); 2016 Feb; 55(2):367-76. PubMed ID: 26370400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
    Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
    Front Immunol; 2021; 12():627986. PubMed ID: 34093522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The vicious circle that leads to rheumatoid arthritis; experimental evidence of the steps involved in this circle].
    van Venrooij WJ; Pruijn GJ
    Ned Tijdschr Geneeskd; 2009; 153():B232. PubMed ID: 19785789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.
    Alpizar-Rodriguez D; Mueller RB; Möller B; Dudler J; Ciurea A; Zufferey P; Kyburz D; Walker UA; von Mühlenen I; Roux-Lombard P; Mahler M; Lamacchia C; Courvoisier DS; Gabay C; Finckh A
    Rheumatology (Oxford); 2017 Sep; 56(9):1579-1585. PubMed ID: 28859327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?
    Tracy A; Buckley CD; Raza K
    Semin Immunopathol; 2017 Jun; 39(4):423-435. PubMed ID: 28337522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.